The Potential Value of RPS27A in Prognosis and Immunotherapy: From Pan-Cancer Analysis to Hepatocellular Carcinoma Validation
RPS27A had the potential to be a biomarker for diagnosis, prognosis and immunotherapy response in pan-cancer, and targeting RPS27A may provide new ideas for cancer immunotherapy.
Authors
- Xingwang Kuai (ORCID: https://orcid.org/0000-0003-0527-7108)
- Juling Ji (ORCID: https://orcid.org/0000-0001-6500-8052)
- Chunbin Wang (ORCID: https://orcid.org/0000-0002-3299-130X)
- Fengli Wang (ORCID: https://orcid.org/0000-0002-3461-6204)
- Xiaoqian He
- Chenyu Wei
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
Publication Details
- Journal
- ImmunoTargets and Therapy
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/itt.s493217
- Citations
- 9
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 2.10